Howland Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
51,607
-9,543
-16% -$250K 0.04% 152
2026
Q1
$1.72M Buy
61,150
+3,956
+7% +$105K 0.07% 121
2025
Q4
$1.42M Buy
57,194
+3,891
+7% +$98.1K 0.05% 128
2025
Q3
$1.36M Buy
53,303
+10,390
+24% +$256K 0.05% 140
2025
Q2
$1.04M Sell
42,913
-5,370
-11% -$125K 0.04% 152
2025
Q1
$1.22M Sell
48,283
-14,218
-23% -$372K 0.05% 141
2024
Q4
$1.66M Buy
62,501
+3,164
+5% +$85.8K 0.07% 119
2024
Q3
$1.72M Sell
59,337
-2,407
-4% -$70.2K 0.07% 113
2024
Q2
$1.73M Sell
61,744
-1,397
-2% -$38.5K 0.08% 106
2024
Q1
$1.75M Sell
63,141
-4,931
-7% -$137K 0.08% 107
2023
Q4
$1.96M Sell
68,072
-4,248
-6% -$128K 0.1% 100
2023
Q3
$2.4M Sell
72,320
-2,175
-3% -$76.9K 0.14% 89
2023
Q2
$2.73M Sell
74,495
-463
-0.6% -$18K 0.16% 83
2023
Q1
$3.06M Sell
74,958
-5,269
-7% -$228K 0.18% 77
2022
Q4
$4.11M Buy
80,227
+1,700
+2% +$81.5K 0.25% 71
2022
Q3
$3.44M Buy
78,527
+4,833
+7% +$235K 0.22% 71
2022
Q2
$3.86M Buy
73,694
+11,821
+19% +$602K 0.24% 67
2022
Q1
$3.2M Buy
61,873
+2,213
+4% +$115K 0.17% 70
2021
Q4
$3.52M Buy
59,660
+160
+0.3% +$7.93K 0.18% 69
2021
Q3
$2.56M Sell
59,500
-610
-1% -$27K 0.13% 82
2021
Q2
$2.35M Sell
60,110
-1,990
-3% -$77.4K 0.12% 90
2021
Q1
$2.25M Buy
62,100
+3,666
+6% +$130K 0.13% 87
2020
Q4
$2.15M Sell
58,434
-3,390
-5% -$124K 0.13% 84
2020
Q3
$2.15M Sell
61,824
-475
-0.8% -$16.7K 0.14% 82
2020
Q2
$1.93M Sell
62,299
-742
-1% -$25.2K 0.14% 82
2020
Q1
$1.95M Sell
63,041
-4,001
-6% -$136K 0.17% 79
2019
Q4
$2.49M Sell
67,042
-3,747
-5% -$133K 0.18% 79
2019
Q3
$2.41M Buy
70,789
+5,765
+9% +$210K 0.18% 80
2019
Q2
$2.67M Sell
65,024
-3,142
-5% -$125K 0.21% 77
2019
Q1
$2.75M Sell
68,166
-6,417
-9% -$257K 0.22% 75
2018
Q4
$3.09M Sell
74,583
-5,229
-7% -$217K 0.29% 74
2018
Q3
$3.34M Sell
79,812
-135
-0.2% -$5.2K 0.25% 78
2018
Q2
$2.75M Sell
79,947
-1,202
-1% -$41.1K 0.22% 83
2018
Q1
$2.73M Sell
81,149
-3,159
-4% -$109K 0.22% 81
2017
Q4
$2.9M Sell
84,308
-106
-0.1% -$3.61K 0.23% 77
2017
Q3
$2.86M Buy
84,414
+36
+0% +$1.16K 0.24% 75
2017
Q2
$2.69M Buy
84,378
+6,268
+8% +$198K 0.23% 80
2017
Q1
$2.54M Sell
78,110
-5,354
-6% -$169K 0.22% 81
2016
Q4
$2.57M Buy
83,464
+29,522
+55% +$901K 0.24% 77
2016
Q3
$1.73M Sell
53,942
-5,180
-9% -$173K 0.16% 88
2016
Q2
$1.98M Buy
59,122
+150
+0.3% +$4.79K 0.19% 82
2016
Q1
$1.66M Sell
58,972
-27,399
-32% -$783K 0.17% 85
2015
Q4
$2.65M Buy
86,371
+7,964
+10% +$251K 0.27% 76
2015
Q3
$2.34M Buy
78,407
+32
+0% +$1.03K 0.25% 73
2015
Q2
$2.49M Buy
78,375
+27
+0% +$880 0.26% 78
2015
Q1
$2.59M Sell
78,348
-379
-0.5% -$12K 0.26% 74
2014
Q4
$2.33M Sell
78,727
-229
-0.3% -$6.57K 0.23% 80
2014
Q3
$2.21M Buy
78,956
+743
+0.9% +$20.9K 0.23% 82
2014
Q2
$2.2M Buy
78,213
+1,293
+2% +$36.9K 0.23% 83
2014
Q1
$2.34M Buy
76,920
+8,853
+13% +$264K 0.27% 76
2013
Q4
$1.98M Sell
68,067
-633
-0.9% -$18.4K 0.25% 80
2013
Q3
$1.87M Buy
68,700
+41,475
+152% +$1.13M 0.26% 79
2013
Q2
$723K Buy
+27,225
New +$752K 0.11% 93

Other funds holding PFE

Howland Capital Management's PFE Position: Q2 2026 in Review

Howland Capital Management reduced its Pfizer (PFE) stake by 16% in Q2 2026, selling an estimated $250K and leaving 51,607 shares worth $1.24M. The position accounts for 0.04% of the portfolio, ranked #152.

Howland Capital Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.11M in Q4 2022. 900 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Howland Capital Management held 51,607 shares of Pfizer worth $1.24M as of Q2 2026.
  • Howland Capital Management sold 9,543 Pfizer shares in Q2 2026, an estimated $250K.
  • Pfizer made up 0.04% of Howland Capital Management's portfolio in Q2 2026, its #152 holding.
  • Howland Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Howland Capital Management's Pfizer position peaked at $4.11M in Q4 2022.
  • 900 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Howland Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.